Selective serotonin reuptake inhibitor

All posts tagged Selective serotonin reuptake inhibitor

Now You Can’t Drink…Water | The Fix.

The Fix

http://www.thefix.com

Sedative-fed perch photo via

By Matt Harvey

03/13/13

The idea that we’re being unwittingly drugged when we drink a glass of ordinary tap water smacks of dystopian science fiction or political conspiracy theory. Accusations that Communists were spiking America’s water with sedatives—under the cover of the federally instituted fluoridation program—were such a staple of Cold War–era paranoia that Stanley Kubrick satirized it in his 1964 masterpiece, Dr. Strangelove. While such fear-mongering may seem quaint, what’s truly ironic is that Americans today are consuming prescription drugs—including addictive psychoactive ones—via the water supply. Who knew?

There’s a good chance that if you live in an urban area, your tap water is laced with tiny amounts of antidepressants (mostly SSRIs like Prozac and Effexor), benzodiazepines (like Klonopin, used to reduce symptoms of substance withdrawal) and anticonvulsants (like Topomax, used to treat addiction to alcohol, nicotine, food and even cocaine and crystal meth). Such are the implications of environmental studies that have been leaking out over the past decade. Whether or not this psychoactive waste has any effect on the human nervous system remains unclear, but when such pharmaceuticals are introduced into the ecosystem, the fallout for other species is demonstrable—and potentially dire.

There’s no mystery to the way prescription medications wind up in our tap water. Whether you flush a bottle of old pills down the toilet or, more likely, excrete the remains of a daily dose (an estimated 80% isn’t broken down in our bodies), active chemicals get recycled back into reservoirs because sewage treatment plants aren’t able to filter them out. “They just fly right through,” says Michael Thomas, an associate professor of bioinformatics at Idaho State University.

Although government officials and scientists are in no rush to look into this potential threat, some environmentalists are becoming worried. In a preliminary study at the University of Idaho, fathead minnows were plunked in water spiked with a combination of SSRIs and anticonvulsants—a lab version of American tap water. After swimming in the contaminated water for 18 days, the minnows exhibited 324 genetic alterations associated with human neurological disorders, including autism.

Mutated minnows admittedly do not signal a hazard of global-warming dimensions. Yet messed-up genes are what cause disease. Studies have shown that regular doses of SSRIs can sometimes damage human DNA, most notably in sperm. The minnows offer evidence that even trace amounts of SSRIs can infiltrate DNA. For now, the implications for humans of ongoing exposure can only be extrapolated from the effects on wildlife: According to a 2008 AP investigation, trace pharmaceuticals already contaminate a wide variety of species, from algae on up to mammals.

Full story—>>>

Now You Can’t Drink…Water | The Fix.

Can 5-HTP really curb depression and anxiety?.

NaturalNews

May 22, 2012 by: Danna Norek

5-Hydroxytryptophan

5-Hydroxytryptophan

Depression and anxiety remain two of the most pervasive mental health issues in American culture today. We currently have more medications than we’ve ever had to treat these conditions along with more natural, gentler alternatives like 5-HTP, St. John’s Wort, and others. Yet it seems both depression and anxiety have ballooned over the past several decades for reasons that can only be speculated upon.

5-HTP is a natural alternative to anti-anxiety medications. It can also be useful in the treatment of mild to moderate depression. It is a popular alternative to medications due to the limited side effects and fairly easy tolerance most people demonstrate with this compound.

5-HTP is short for its longer name: 5-Hydroxytryptophan. It is a natural compound that is produced by your body which acts as a precursor to the important “happiness” neurotransmitter called serotonin and the “sleep” hormone melatonin.

Serotonin is of vital importance to your sense of well being. A shortage of this neurotransmitter has been detected in those with excessive amounts of anxiety, depression symptoms, and even eating disorders such as bulimia.

It is thought that 5-HTP acts similarly to SSRI drugs or selective serotonin re-uptake inhibitors, but without some of the harsh side effects. Taking a natural supplement such as 5-HTP also does not typically result in the withdrawal symptoms many antidepressants have upon weaning off of or quitting them.

Patients cannot simply stop most antidepressant medications “cold turkey.” This is why many view antidepressants as a lifetime or long term commitment. Stopping many antidepressants suddenly and without any tapering off can experience devastating symptoms.

Patients may experience panic episodes or a severe recurrence of their depression after stopping these medications. 5-HTP is a more subtle, indirect and gentle therapy for increasing your levels of serotonin, therefore it should not have the extreme withdrawal symptoms. That being said it is always wise to also taper off natural therapies where possible to reduce any potential symptoms or sensitivities.

5-HTP has been studied for its potentially therapeutic effects for insomnia, depression, migraines, and even fibromyalgia, which is a condition marked by chronic pain and lethargy. All studies confirmed that taking varying dosages of this supplement improved all of these conditions in most patients.

The study that looked at 5-HTP as a potential antidepressant alternative found that the supplement worked better than a placebo on patients with depressive symptoms. However, several other clinical studies which showed 5-HTP worked as well as various antidepressants over time were dismissed because they didn’t meet certain “quality standards.”

Side effects reported in some that take 5-HTP include nausea, diarrhea, and dizzy spells although these are not the norm. Due to its relaxing effect on the nervous system it also may make some people a little sleepy. Not everyone will experience this particular side effect. It just depends on your chemistry and personal tolerance levels.

Additionally, 5-HTP may have interactions with some medications. If you are taking any other medications or herbal supplements, be sure to look them up or consult with a professional if you suspect a potential for interaction.

Anxiety

Anxiety (Photo credit: Alaina Abplanalp Photography)

Sources for this article include:

http://www.5-htp.net/depression.asp
http://www.fyiliving.com

Antidepressants Might Cause Harm to Heart, Brain, and Bones | Natural Society.

Patrick Gallagher
April 15, 2012

NaturalSociety
depressedboy 220x137 Antidepressants Could Cause Harm to Heart, Brain, and BonesDid you know that roughly 10% of the American population suffers from depression? It isn’t exactly a coincidence, with the FDA approving a wide variety of damaging foods and drugs that many millions of Americans consume each day. The FDA isn’t helping the population with their approval of the dozens of antidepressant medications on the market – it in fact is doing the exact opposite.
The beneficial results of antidepressants have been under the spotlight for quite some time in the health world, and the validity of giving them out like candy to patients in need of a quick and easy solution is under question as well; just how useful is medication for depression? At best, the tangible results felt by patients are comparable to sugar pills. That is to say, the medication itself does virtually nothing to improve the mood of the patient directly. At worst, antidepressants cause decreased mental stability. Wanting to kill yourself or others around you are feelings which antidepressants have been shown to ignite.

There is even the possibility that while on these terrible drugs you can become even more vulnerable to more serious mental illnesses – all whilst other legitimate non-medication methods for treating depression are being tread underfoot by the FDA.

In more recent studies, there has been surfacing evidence that antidepressants cause arteries to thicken at a faster rate. One some cases, research specifically points to an increased thickness of the lining of the carotid artery by up to 5% in men, thereby increasing the risk of heart disease substantially by putting more pressure on the heart. This occurs when on both selective serotonin reuptake inhibitors (SSRIs, the primary form of antidepressants) and antidepressants that affect other chemicals in the brain. The evidence isn’t completely concrete, but it points towards the change of serotonin in the body caused by the medications.

Another study in women who have gone through menopause unveiled that women who take either variation of antidepressants were up to 45% more likely to suffer from life threatening brain damage from a stroke. This same study also found that women’s death rates rose 32% more whilst on the drugs.

Other side effects that are documented in both normal people and scientists are much more prominent, but certainly no less detrimental to your health. These include those suicidal/homicidal thoughts mentioned earlier, as well as an increased risk of diabetes, an increased possibility of stillbirth, lowered immune system support and reduced bone density -  resulting in a higher risk of fractures, primarily in the spinal column.

There are also a few long term risks with using these detrimental drugs: a conversion from unipolar depression to bipolar depression, and an overall cognitive decline in most users. If becoming bipolar unnecessarily does not steer you away from these, then the overall loss of your mental capacity should be enough to raise a warning flag.

Explore More:

  1. Antidepressants Cause Your Arteries to Thicken 400% More Than Aging
  2. Antidepressants Drastically Increase the Risk for Miscarriages
  3. Antidepressants Make You More Depressed and Trigger Suicidal Thoughts
  4. Antidepressants Proven to be Useless, Pushed on Public Anyway
  5. Antidepressants Increase Breast Cancer Risk
  6. Antidepressants Prescribed Without Psychiatric Diagnosis

Mike Barrett

Depression may be the worst emotional experience there is. The causes are many, and it often drives people to zig-zag past everything that matters and into a pill bottle of pharmaceutical ‘treatments’.

But these solutions offered by the pharmaceutical industry are nothing but a sham, and their antidepressant products only make you more depressed and trigger suicidal thoughts. One study has also found that antidepressants cause your arteries to thicken 400% more than aging – a main factor in the thickening of the arteries.

Antidepressants Linked to Heart Disease and Stroke

A study conducted by the Emory University School of Medicine included over 500 middle-aged male twins, both who served in the U.S. military during the Vietnam War. The researchers noted that among 59 pairs of twins where only one brother was on antidepressants, the one ingesting the drugs usually had higher carotid intima-media thickness (IMT) – the thickness of main arteries in the neck.

‘One of the strongest and best-studied factors that thickens someone’s arteries is age, and that happens at around 10 microns per year…In our study, users of antidepressants see an average 40 micron increase in IMT, so their carotid arteries are in effect four years older,’ says the first study author Amit Shah, MD.

The most commonly prescribed antidepressants are known as selective serotonin reuptake inhibitors (SSRIs), such as Prozac.

Researchers found that participants who used SSRIs, which were 60 percent of those taking antidepressants, had higher carotid IMT. This may be due to the effects antidepressants have on serotonin levels, which is a chemical in your body that helps some brain cells communicate.

These findings are just one more thing to add to the long list of why people shouldn’t be taking many harmful pharmaceuticals. More than 1 in 10 Americans are on these suicide-linked antidepressants even though they do not work and only make the problem worse.

Instead of resorting to these pharmaceuticals, try supplementing with vitamin D, as it has been shown to defeat depression naturally. It is also key to de-stress the brain, as depression is always cultivated from stress-related aspects of your life.

via Antidepressants Cause Your Arteries to Thicken 400% More Than Aging | Republic Broadcasting Network.

life made colourful with prozac

400% Rise in Anti-Depressant Pill Use: Americans Are Disempowered — Can the OWS Uprising Shake Us Out of Our Depression? | Drugs | AlterNet.

Is it time to repoliticize a great deal of our despair, and reconsider the old-fashioned antidepressant of political activism?

The U.S. Centers for Disease Control and Prevention (CDC) recently reported that antidepressant use in the United States has increased nearly 400 percent in the last two decades, making antidepressants the most frequently used class of medications by Americans ages 18-44. Among Americans 12 years and older, 11 percent were taking antidepressants by 2005-2008 (the most recently reported study period), and 23 percent of women ages 40–59 years were taking them.

Why has U.S. antidepressant use skyrocketed? Are the symptoms of what is commonly called depression—helplessness, hopelessness, and immobilization—always evidence of a medical condition? Or is it time to repoliticize a great deal of our despair, and reconsider the old-fashioned antidepressant of political activism?

Common Explanations for Soaring Antidepressant Use

Nowhere in the CDC report is there any explanation for the 400 percent increase of antidepressant use from 1988 to 2008, however, there are several common explanations offered by mental health professionals and journalists.  

Money is a large factor. It has become more lucrative for psychiatrists and other physicians to prescribe medication than to provide talk therapy. This was detailed in the New York TimesMarch 2011 investigative report “Talk Doesn’t Pay, So Psychiatry Turns Instead to Drug Therapy” which reported, “A 2005 government survey found that just 11 percent of psychiatrists provided talk therapy to all patients.” Actually, most antidepressant prescriptions are written by physicians other than psychiatrists and, according to the recent CDC report, among Americans taking one antidepressant, less than one-third of them  have seen a mental health professional in the past year.  

Antidepressant use has also skyrocketed because of the increased practice of prescribing antidepressants for many conditions other than severe depression, and prescribing them for longer periods of time. Among the 2005-2008 antidepressant user group (no data offered on earlier study periods), only 33.9 percent had severe symptoms of depression; 28.4 percent of antidepressant users had moderate symptoms; and 19.2 percent had mild symptoms; while 7.6 percent had no depression symptoms. And, according to the CDC report, more than 60 percent of Americans who are taking antidepressants have taken them for 2 years or longer, with 14 percent having taken them for 10 years or more. 

According to antidepressant manufacturers, the increase in antidepressant use has been caused by their creation of more effective antidepressants, including the so-called selective serotonin reuptake inhibitors (SSRIs) such as Prozac, Paxil, and Zoloft which came on the market in the late 1980s and early 1990s. However, by the late 1990s, psychiatry textbooks had already rejected the idea of increased effectiveness of SSRIs (for example, Robert Julien’s A Primer of Drug Action (1998) states, “The newer antidepressants [SSRIs] are not necessarily more effective than the older TCAs [tricyclics] ).”  

Rather than SSRIs’ greater effectiveness, it was their greater publicity that stimulated public acceptance. One publicity coup commenced in 1997 when U.S. government agencies changed the rules for broadcast advertising, no longer requiring full information about side effects (which had previously made it problematic for drug companies to run a thirty-second spot). TV advertising dramatically increased patient requests for antidepressants from their physicians. A study reported in 2005 by the Journal of the American Medical Association, “Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants,” concluded, “Patients’ requests have a profound effect on physician prescribing.” 

A Neglected Explanation: The Depoliticizing of Despair

A largely neglected explanation for the huge growth of antidepressant use is that Americans have increasingly been socialized to equate all states of demoralization and immobilizing despair with a medical condition, and to seek medical treatment rather than political remedies. 

Depression is highly associated with a variety of overwhelming pains, including physical pain, relationship pain (such as a dissatisfying marriage and social isolation), trauma—and financial pains.  

Financial pains include unemployment, poverty, and debt. In 2007 the U.S. Substance Abuse & Mental Health Services Administration reported depression in 12.7 percent of unemployed people compared to 7 percent of employed people. And the Urban Institute in 1996 reported that Americans on public assistance have at least three times higher rate of depression than those not on public assistance. A person who has suffered mental illness is three times more likely to be in debt than someone who is not in debt, according to Richard Wakerall, director of the U.K. mental health organization Mind in Plymouth. 

Recently, I had a chance encounter at Cincinnati’s Findlay Market with five young adults who reported large student-loan debt and who appeared mildly depressed about it. I happened to be in a charged-up mood, having just participated in an Occupy Cincy march, and I told them that the entire U.S. $1 trillion student-loan debt could be forgiven if the U.S. government paid it off rather than funding the damn military-industrial complex, which costs us over $1 trillion a year if you include everything. They started to smile and look more energized, and three of them seemed interested in the Occupy Cincy movement. If America’s millions of depressed student-loan debtors could politicize their despair and take it to the mall in Washington D.C., we could dwarf the crowds in Tahrir Square. 

Can Activism Be an Antidepressant?

Almost as soon as I entered Freedom Plaza in Washington D.C. on October 6, I experienced a wave of pleasant feelings and energy. My wife, Bon, and I showed up about 10am on the first day of “October 2011” (“Occupy Freedom Plaza”) in Washington D.C. after driving there from Cincinnati. In sharp contrast to the blank and depressed faces that I had just seen on the D.C. Metro and on the D.C. streets, we were now surrounded by a thousand or so people who were smiling, laughing, engaged in political discussions, and eagerly awaiting the day’s events. I chatted with two of the organizers, David Swanson and Margaret Flowers, and found their hope and energy a supreme antidote to cynicism. The opposite of depression is vitality, and so by just stepping into Freedom Plaza, I had received a strong antidepressant.  

Then came the day’s major march. Depression is much about feeling hopeless, alienated, isolated, and powerless, and this march was an antidote to all those feelings. For a couple of hours, we felt some real power. We marched on the streets— not the sidewalks—and traffic was blocked by police, who for those moments in time actually were the People’s servants. We marched past the White House and the Treasury, paused at the U.S. Chamber of Commerce to “drop off some job resumes” and for some short speeches, then up and over to K Street, with many cars honking approval and some non-marchers on the sidewalks raising their fists and shouting encouragement. Then back to the Plaza, and a couple of hours later a General Assembly. 

The General Assembly was attended by about 500 people who experienced, some for the first time, a non-hierarchical, anti-authoritarian, respectful democracy where the issues of the day were discussed. No one was rude  and all seemed jovially patient. We hadn’t planned to stay more than that day, but leaving the Plaza late that evening, we had an urge to return. 

The next morning, I found my pace quicken as I headed from the Metro station back to Freedom Plaza, as I was excited to return to this piece of “federal property” that had begun to feel like a “People’s Oasis.” We had succeeded, at least for the time being, in taking back a small piece of the United States and restoring it to some kind of sanity and humanity. A section of the Plaza was filled with sleeping bags, backpacks and cardboard shelters, and our food, media, and first-aid tents still stood.  

We decided to prolong our visit and stay for the afternoon march to the Martin Luther King Memorial. At this march, there were the chants that are common to all Occupy marches: “We are the 99 percent.” “The banks got bailed out, we got sold out.” “Hey, hey, ho, ho, corporate greed has got to go.” “Show me what democracy looks like. This is what democracy looks like.” On this march, we paused at the International Trade Center (in the Ronald Reagan Building), where there were about 75 demonstrators protesting the tar sands pipeline. As some of our marchers had earlier participated in their protest, the pipeline protesters returned the favor by joining our march. We shouted our appreciation and our morale kicked up another notch. 

Leaving Freedom Plaza at the end of my short stint there, I thought that even a little dose of democracy, especially when it has not been experienced, is the best damn antidepressant that many people will ever experience. And even if the cynics are right and the movement dies from cold weather or gets large enough for the corporatocracy to bring out their tanks and crush it, something still will have been won. Everybody who participated will remember that their demoralization and despair was “cured,” at least for a time, not by a pill or any other consumer product but by their own political actions.  

>Bruce E. Levine is a clinical psychologist and author of Get Up, Stand Up: Uniting Populists, Energizing the Defeated, and Battling the Corporate Elite  (Chelsea Green, 2011). His Web site is www.brucelevine.net.

What if the drugs don’t work? – Features, Health & Families – The Independent.

Research repeatedly shows that antidepressants give little benefit – but serious side effects. Yet millions who take them regard them as lifesavers. Markie Robson-Scott reports on the controversy that is dividing psychiatrists

Tuesday, 25 October 2011

When my American friend Bill, who’d been on SSRI antidepressants for 22 years (Prozac, followed by Paxil, Lexapro, then Celexa), read a two-part article by Dr Marcia Angell in The New York Review of Books recently about the crisis in psychiatry and the inefficacy of antidepressants, he stopped taking his meds (tapering off gradually, monitored by his doctor). “The article brought on enough doubt to push me over,” he said. Since then, his moods have become more volatile – more anger, more emotion, such as crying at the end of the last Harry Potter film (he’s in his 50s). But he’s got his libido back after years of “muffled response” and that seems a worthwhile trade-off.

Instead of listening to Prozac, have we been listening to placebo all along? Research repeatedly appears to show that: antidepressants are little more than placebos, with very little therapeutic benefit but serious side-effects (70 per cent of people on Celexa and Paxil report sexual dysfunction, and in some, it carries on even when they stop taking the pills). The theory of chemical imbalance as a cause of depression is an unproven hypothesis; and doctors are prescribing the drugs mainly because of the “juggernaut of pharmaceutical promotion”, as the US psychiatrist Dr Daniel Carlat calls it.

It’s not surprising there’s a US media furore – about 10 per cent of Americans over the age of six take antidepressants. In the UK, prescriptions for the drugs went up 43 per cent in the last four years to 23 million a year.

Professor Irving Kirsch, associate director of the programme in placebo studies at Harvard Medical School and author of The Emperor’s New Drugs: Exploding the Antidepressant Myth, says the theory of chemical imbalance – that there is not enough serotonin, norepinephrine and/or dopamine in the brain synapses of depressed people – doesn’t fit the data (lowering serotonin levels in healthy patients has no impact on their moods). Chemical imbalance is a myth, he says. It follows that the idea that “antidepressants can cure depression chemically is simply wrong”. His meta-analysis of 38 clinical studies – 40 per cent of which had been withheld from publication because drug companies didn’t like the results – involving more than 3,000 depressed patients on SSRIs shows that only 25 per cent of the benefit of antidepressant treatment was due to the drugs and that 50 per cent was a placebo effect. “In other words, the placebo effect was twice as large as the drug effect,” though the placebo response was lower in the severely depressed.

This is not quite as damning as it sounds: placebos are extraordinarily powerful and can be “as strong as potent medications”. Placebo response is specific: placebo morphine eases pain, placebo antidepressants relieve depression. It’s a question of expectancy and conditioning: if you expect to feel better, you will, even if you’re getting negative side effects, because side effects, Kirsch says, convince people that they’ve been given a potent drug.

Psychotherapy boosts the placebo effect and is “significantly more effective than medication” for all levels of depression, he says. Antidepressants should only be used “as a last resort and only for the most severely depressed”.

Of course, not everyone agrees. Ian Anderson, Professor at psychiatry at the University of Manchester, who is to debate whether “antidepressants are useful in the treatment of depression” with Kirsch at a conference in Turkey next month, thinks we’re in danger of throwing the baby out with the bathwater when we say antidepressants are rubbish. Antidepressants are part of a doctor’s toolbox, though probably most useful for the most depressed; some people don’t take to talking therapies; it’s not an either/or situation, he says.

Professor Allan Young, chair of psychiatry at Imperial College London, agrees. “Depression is such a huge category of illness – there are multiple types, and each type responds differently.” Of course, the brain and the body are inextricably linked, he says, and placebo effects are greater in the less-severely ill.

To make things more complicated, there’s the nocebo effect. If you expect to feel bad when you come off antidepressants, you will, because “we tend to notice random small negative changes and interpret them as evidence that we are in fact getting worse”, Kirsch says.

Lucy, who was suicidal, took Cipramil (Celexa in the US) on and off for 10 years. She says the drug “gave me back myself, it was like a ray of light shining through fog”, but the side effects – nausea and lost libido among others – forced her off it. Then “it was like a clock ticking, a twitch in the back of my mind. I lived in fear of the depression coming back. The only thing that kept me alive was knowing the pills were there. But was it because I believed I was a depressive so when I had the negative feelings I panicked?”

For Judy, lofepramine, a tricyclic, worked well. “First I was given Prozac, which gave me huge anxiety, like a bad trip, and made me horribly aware of all my nerve-endings. But lofepramine worked from the first day. When I took it in the morning I’d get a chemical lift, like a switch being turned on: it was a fabulous rush of joy.”

She stopped taking it after six months. Several months later, she felt low, though not depressed – “I feel depression like a stone in my solar plexus, and it wasn’t like that. But still I thought it would be nice to have that short-cut to happiness, so I took a lofepramine and it had no effect whatsoever – because I wasn’t really depressed. So to me the placebo theory makes no sense.” Neither does it to Hannah, who took Prozac for 10 years and says “it was absolutely fantastic and saved my life”.

Daniel Carlat, a psychiatrist in Boston and author of Unhinged: The Trouble with Psychiatry – A Doctor’s Revelations about a Profession in Crisis says that prescribing is a hit-and-miss affair. “Unfortunately we know a good bit less about what we are doing than you might think,” he writes. “When I find myself using phrases like ‘chemical imbalance’ and ‘serotonin deficiency’, it is usually because I’m trying to convince a reluctant patient to take a medication. Using these words makes their illness seem more biological, taking some of the stigma away.”

Most lay people, he says, don’t realise how little shrinks know about the underpinning of mental illness, though he’s not as convinced as Kirsch about the placebo effect and makes the point that the patients who turn up at his office are different from those recruited into clinical trials because drug companies, desperate to get their product to outperform a placebo, are picky about who they choose.

You have to have “pure” depression, unblemished by alcohol use, anxiety problems, bipolar disorder, suicidal thoughts, mild or long-term depression – which, says Carlat, would exclude most of his patients. Yet, as Marcia Angell, author of The Truth About the Drug Companies: How They Deceive Us and What to Do About It, says: “It’s true… but they are the best we have.”

If there’s one thing that’s clear among the contradictions, it’s that the brain remains mysterious. As Carlat says: “Undoubtedly, there are neurobiological and genetic causes for all mental disorders, but they are still beyond our understanding.” All we really know is that depression exists and that sometimes the drugs seem to work – even if it’s a placebo effect.

Antidepressants: the guidelines

* Never stop taking antidepressants without discussing it with your doctor, because abrupt cessation of SSRIs can cause withdrawal symptoms that can be both physical and mental.

* If you do decide to stop, you’ll need to reduce the dose gradually rather than stopping abruptly.

* If you’re happy with your antidepressant and you feel it works for you, then keep on taking it. Regular use is what works: if it ain’t broke, don’t fix it, says Professor Irving Kirsch.

Further reading: Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America by Robert Whitaker

Some of the common painkillers such as Aspirin and Ibuprofen may negatively affect the efficacy of the SSRIs, the most widely used antidepressants.

The SSRIs (selective serotonin reuptake inhibitors) such as Prozac and Celexa are a class of antidepressants commonly taken for depression, anxiety and obsessive-compulsive disorder.

Rockefeller University researchers studied the effect of giving non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin to the mice that were already taking Celexa.

The findings showed lower blood levels of Celexa in the mice taking the combination of the antidepressant and a NSAIDs painkiller.

Reportedly, the symptoms of depression decreased by 55 percent in patients taking an antidepressant and NSAID together while only 45 percent of those who were taking an anti-inflammatory alone experienced a significant relief of depressive symptoms.

Compared with those taking antidepressant alone, mice consuming a combination of painkiller and antidepressant also did worse on tests measuring their stress and depression levels, according to the report published in the journal Proceedings of the National Academy of Sciences.

Moreover, the researchers found the same results after analyzing data from a previous study which had followed more than 4,000 people treated with antidepressants for over 7 years.

“It appears there’s a very strong antagonistic relationship between NSAIDs and SSRIs,” said lead author Jennifer Warner-Schmidt. “This may be one reason why the response rate (in patients of SSRIs) is so low.”

Researchers, however, failed to distinguish between individuals who had taken NSAID only once or twice in the past 12 weeks and those who were regularly taking the drug for conditions such as arthritis.

They were also incapable of reporting the main cause contributing to the findings; as a result, further studies are needed to assess the interaction between NSAIDs and SSRIs.

PressTV – Painkillers cut antidepressants efficacy.

How to Overcome Depression

Image by kevindooley via Flickr

Sunday, April 03, 2011 8:37

Antidepressant use has been linked to thicker arteries, possibly contributing to the risk of heart disease and stroke, in a study of twin veterans. The data is being presented Tuesday, April 5 at the American College of Cardiology meeting in New Orleans. 

Depression can heighten the risk for heart disease, but the effect of antidepressant use revealed by the study is separate and independent from depression itself, says first author Amit Shah, MD, a cardiology fellow at Emory University School of Medicine. The data suggest that antidepressants may combine with depression for a negative effect on blood vessels, he says. Shah is a researcher working with Viola Vaccarino, MD, PhD, chair of the Department of Epidemiology at Emory’s Rollins School of Public Health.

The study included 513 middle-aged male twins who both served in the U.S. military during the Vietnam War. Twins are genetically the same but may be different when it comes to other risk factors such as diet, smoking and exercise, so studying them is a good way to distill out the effects of genetics, Shah says.

Researchers measured carotid intima-media thickness – the thickness of the lining of the main arteries in the neck — by ultrasound. Among the 59 pairs of twins where only one brother took antidepressants, the one taking the drugs tended to have higher carotid intima-media thickness (IMT), even when standard heart disease risk factors were taken into account. The effect was seen both in twins with or without a previous heart attack or stroke. A higher level of depressive symptoms was associated with higher IMT only in those taking antidepressants.

“One of the strongest and best-studied factors that thickens someone’s arteries is age, and that happens at around 10 microns per year,” Shah says. “In our study, users of antidepressants see an average 40 micron increase in IMT, so their carotid arteries are in effect four years older.”

Antidepressants’ effects on blood vessels may come from changes in serotonin, a chemical that helps some brain cells communicate but also functions outside the brain, Shah says. The most commonly prescribed antidepressants are selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac), which increase the level of serotonin in the brain. Other types of antidepressants also affect serotonin levels, and antidepressants can act on other multi-functional brain chemicals such as norepinephrine.

In the study, researchers saw higher carotid IMT in both participants who used SSRIs (60 percent of those who took antidepressants) and those who used other types of antidepressants.

Most of the serotonin in the body is found outside the brain, especially in the intestines, Shah notes. In addition, serotonin is stored by platelets, the cells that promote blood clotting, and is released when they bind to a clot. However, serotonin’s effects on blood vessels are complex and act in multiple ways. It can either constrict or relax blood vessels, depending on whether the vessels are damaged or not.

“I think we have to keep an open mind about the effects of antidepressants on neurochemicals like serotonin in places outside the brain, such as the vasculature. The body often compensates over time for drugs’ immediate effects,” Shah says. “Antidepressants have a clinical benefit that has been established, so nobody taking these medications should stop based only on these results. This isn’t the kind of study where we can know cause and effect, let alone mechanism, and we need to see whether this holds up in other population groups.”

Contacts and sources:

Antidepressants Linked To Thicker Arteries, Strokes and Heart Disease by Emory Study | Before It’s News.

Picture taken by myself of my Adderall prescri...

Image via Wikipedia

When people consider the connections between drugs and violence, what typically comes to mind are illegal drugs like crack cocaine. However, certain medications — most notably, some antidepressants like Prozac — have also been linked to increase risk for violent, even homicidal behavior.

A new study from the Institute for Safe Medication Practices published in the journal PloS One and based on data from the FDA’s Adverse Event Reporting System has identified 31 drugs that are disproportionately linked with reports of violent behavior towards others. (More on Time.com: New Hope For An Anti-Cocaine Vaccine)

Please note that this does not necessarily mean that these drugs cause violent behavior. For example, in the case of opioid pain medications like Oxycontin, people with a prior history of violent behavior may seek  drugs in order to sustain an addiction, which they support via predatory crime. In the case of antipsychotics, the drugs may be given in an attempt to reduce violence by people suffering from schizophrenia and other psychotic disorders — so the drugs here might not be causing violence, but could be linked with it because they’re used to try to stop it.

Nonetheless, when one particular drug in a class of nonaddictive drugs used to treat the same problem stands out, that suggests caution: unless the drug is being used to treat radically different groups of people, that drug may actually be the problem. Researchers calculated a ratio of risk for each drug compared to the others in the database, adjusting for various relevant factors that could create misleading comparisons.  Here are the top ten offenders:

10. Desvenlafaxine (Pristiq) An antidepressant which affects both serotonin and noradrenaline, this drug is 7.9 times more likely to be associated with violence than other drugs.

9. Venlafaxine (Effexor) A drug related to Pristiq in the same class of antidepressants, both are also used to treat anxiety disorders. Effexor is 8.3 times more likely than other drugs to be related to violent behavior. (More on Time.com: Adderall May Not Make You Smarter, But It Makes You Think You Are)

8. Fluvoxamine (Luvox) An antidepressant that affects serotonin (SSRI), Luvox is 8.4 times more likely than other medications to be linked with violence

7. Triazolam (Halcion) A benzodiazepine which can be addictive, used to treat insomnia. Halcion is 8.7 times more likely to be linked with violence than other drugs, according to the study.

6) Atomoxetine (Strattera) Used to treat attention-deficit hyperactivity disorder (ADHD), Strattera affects the neurotransmitter noradrenaline and is 9 times more likely to be linked with violence compared to the average medication.

5) Mefoquine (Lariam) A treatment for malaria, Lariam has long been linked with reports of bizarre behavior. It is 9.5 times more likely to be linked with violence than other drugs.

4) Amphetamines: (Various) Amphetamines are used to treat ADHD and affect the brain’s dopamine and noradrenaline systems. They are 9.6 times more likely to be linked to violence, compared to other drugs.

3) Paroxetine (Paxil) An SSRI antidepressant, Paxil is also linked with more severe withdrawal symptoms and a greater risk of birth defects compared to other medications in that class. It is 10.3 times more likely to be linked with violence compared to other drugs. (More on Time.com: Healthland’s Guide to Life 2011)

2) Fluoxetine (Prozac) The first well-known SSRI antidepressant, Prozac is 10.9 times more likely to be linked with violence in comparison with other medications.

1) Varenicline (Chantix) The anti-smoking medication Chantix affects the nicotinic acetylcholine receptor, which helps reduce craving for smoking. Unfortunately, it’s 18 times more likely to be linked with violence compared to other drugs — by comparison, that number for Xyban is 3.9 and just 1.9 for nicotine replacement. Because Chantix is slightly superior in terms of quit rates in comparison to other drugs, it shouldn’t necessarily be ruled out as an option for those trying to quit, however.

Top Ten Legal Drugs Linked to Violence – TIME Healthland.

As new research reveals antidepressants raise the danger of heart attacks, the disturbing cost of this modern addiction

By John Naish
Last updated at 10:14 PM on 13th December 2010
“In my view, it’s fast becoming one of the greatest medical scandals of our age.”
Dr Mark Hamer, a ­public health researcher at University ­College ­London,

Just as David Cameron launches his campaign to boost national happiness, along comes grim news for the 12 million Britons taking happy pills. London-based researchers have just announced that antidepressants raise the risk of fatal heart attacks.

This research is only the latest wake-up call for a nation hooked on happy pills. Might we finally heed the warnings and shake ­ourselves out of our pharmaceutical stupor?

It is high time we did: a small mountain of studies shows that antidepressant drugs are largely ineffective. But more than that, they can ruin lives by creating chronic dependency and a grinding ­hopelessness that ­sometimes leads to self-neglect and death.
The latest study, by Dr Mark Hamer, a ­public health researcher at University ­College ­London, shows that people on the older drugs — tricyclic antidepressants — are at far higher risk of cardiovascular disease than those ­taking the newer class of pills, selective ­serotonin reuptake inhibitors (SSRIs).

But if I were taking SSRIs, I would not be cheered by the findings. Tricyclics were ­discovered in the Forties and it is only now we have identified these dangerous effects.

Moreover, some SSRI drugs are known to cause serious problems such as stomach bleeding. In addition, the withdrawal ­symptoms can be so severe that patients may become dependent on them.

Dr Hamer says his findings do not only affect people with depression, because antidepressants are also prescribed to people with back pain, headache, anxiety and sleeping problems.

Last year, according to Dr ­Hamer’s ­figures, about 33 million antidepressant prescriptions were dispensed in England.

At some point, surely, there will be no one left to prescribe for. In my view, it’s fast becoming one of the greatest medical scandals of our age.

The most worrying thing about these drugs is not their side-effects, but their widespread non-effect: they just don’t work for most ­people with mild to moderate depression.

Two years ago, researchers at Hull ­University concluded that the pills only benefit ­people who are most seriously, clinically depressed. In these extreme cases, there is often a physical problem in their brain, a result of genetics or accident. But what of the rest?

There is a growing view that many people are being needlessly drugged because the natural state of feeling unhappy is viewed as an illness, rather than a ­normal part of life that we should experience and learn from.

An American study of 8,000 ­people who had been treated for depression found that a quarter of them were not clinically sick, but had just undergone a normal life event such as bereavement.

Their symptoms, it said, should be left to pass naturally (that, of course, would be a blow to the drug manufacturers, who profit so handsomely from the mass ­consumption of their mind-numbing chemicals).

‘For most of us, the healthiest option is to face our problems, rather than disappear down a black hole of antidepressant dependency’

One leading expert, Randolph Nesse, a psychiatry professor at Michigan University, argues that this mild form of depression is ­beneficial, often ­interjecting in life to tell us to stop what we are doing and reconsider.

This can help, he says, when something awful happens to us, such as a job loss or relationship break-up, when it makes sense to slow down to grieve, reassess and make changes.

But instead, we live in a world that tells us that when we feel out of sorts we need a pill to recover.

It is this belief that ­creates queues of patients at the doors of hard-pressed GPs, who often feel they have no option but to hand out happy pills as though they were sweeties.

Many patients later claim they couldn’t have coped without them. They will swear that ‘the drugs make me feel better, so they must be working’. But often the drugs do not actually work as chemicals. Instead, they merely reassure us — the so-called placebo effect.

In 2008, Professor Irving Kirsch at Hull University found something strange when he took a close look at some figures from drug manufacturers’ own trials of four common antidepressants.

The drugs improved patients’ sense of wellbeing. So far, so ­unremarkable.

But many of those involved in the trials were given sugar pills instead of antidepressants.

And their depression scores improved just as much as those on the real pharmaceuticals. In other words, the placebo patients put so much store by the magical (and much-promoted) power of antidepressants that they lifted their own morale without any genuine chemical intervention. Such is the life-enhancing power of human belief.
Everybody hurts: Sadness is a part of life and shouldn’t always be treated as an illness

Everybody hurts: Sadness is a part of life and shouldn’t always be treated as an illness

But this phenomenon also has a dark side: the opposite of placebo, which is called the ‘nocebo’ effect.

This occurs when you convince someone that a particular thing will do them harm, and they begin to feel sick.

Talk to someone about food poisoning while they are tucking into a hearty meal and you will see the nocebo effect at work.

Something similar is happening in our pill-obsessed world. When we are convinced that we need drugs to get us out of an ­emotional crisis, we stop doing things to help ourselves.

This was clear from the latest research. Dr Hamer found that tricyclic drugs raise a person’s heart attack risk.

But that risk was dwarfed by another danger: the people ­taking the drugs often lost the will to look after themselves properly. They were more likely to smoke, be overweight and not exercise.

Dr Hamer says that if they started living more healthily they would cut their heart attack risk by three times. Exercise and weight loss would also help alleviate their depression and anxiety.

But people stuck in the role of helpless drug-munchers often ­cannot make that change for themselves.

They simply sit waiting for their questionable pills to work. And when the pills fail, they become even more demoralised. It’s a vicious cycle, and one that’s ­sucking in more and more vulnerable people.

Thankfully, this situation is not entirely hopeless. Such patients may be helped by cognitive behavioural therapy (CBT).

Health department guidelines already state that patients on antidepressants should also be given CBT, but many GPs’ ­budgets will not stretch to providing it.

And what is CBT?

It is a form of talking therapy that encourages depressed patients to exchange their self-destructive thoughts for healthier ways of believing and acting.

It is the modern equivalent of telling people (gently) to shape up, smarten up and take ­responsibility for their own lives.

Except that you could not possibly convey that time-honoured message with such stark clarity these days. Apparently, we are all too fragile to hear such sage advice: the shock might send us rushing to the medicine cabinet.

That is a terrible shame. All the antidepressant drugs and therapy-speak in the world cannot take away the simple, honest fact that life for all of us can be dismally hard at times.

For most of us, though, the healthiest option is to face our problems vigorously, rather than disappear down a black hole of antidepressant dependency.

That is an especially important message to spread during this economic downturn. Times are getting harder.

But instead of grasping for ­tablets, we would be far better off being encouraged to rely on our own resources — positivity and self-reliance.

It is sad news for the ­millions on antidepressants that their drugs may have lethal effects on the heart.

But if such warnings awaken us to the wider damage these pills wreak, they will have done everyone a priceless favour.